BlackRock
NMTR

BlackRock’s 9 Meters Biopharma NMTR Stock Holding History

BlackRock’s Portfolio NMTR Stock Details NMTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-167,949
Closed -$113K – 5620
2023
Q2 		$113K Sell
167,949
-90
-0.1% -$80 ﹤0.01% 4875
2023
Q1 		$234K Sell
168,039
-145
-0.1% -$273 ﹤0.01% 4733
2022
Q4 		$212K Sell
168,184
-187
-0.1% -$426 ﹤0.01% 4837
2022
Q3 		$724K Sell
168,371
-169
-0.1% -$838 ﹤0.01% 4599
2022
Q2 		$880K Sell
168,540
-530,980
-76% -$5M ﹤0.01% 4588
2022
Q1 		$8.38M Sell
699,520
-8,720
-1% -$119K ﹤0.01% 3667
2021
Q4 		$13.9M Buy
708,240
+29,927
+4% +$669K ﹤0.01% 3481
2021
Q3 		$17.6M Buy
678,313
+4,086
+0.6% +$96.3K ﹤0.01% 3369
2021
Q2 		$14.8M Buy
674,227
+486,175
+259% +$11.9M ﹤0.01% 3473
2021
Q1 		$4.4M Buy
188,052
+36,300
+24% +$1.12M ﹤0.01% 3997
2020
Q4 		$2.61M Buy
151,752
+138,153
+1,016% +$2.3M ﹤0.01% 3957
2020
Q3 		$221K Hold
13,599
– – ﹤0.01% 4391
2020
Q2 		$156K Sell
13,599
-4,160
-23% -$46.9K ﹤0.01% 4412
2020
Q1 		$178K Sell
17,759
-147
-0.8% -$1.84K ﹤0.01% 4252
2019
Q4 		$200K Buy
17,906
+816
+5% +$13.6K ﹤0.01% 4318
2019
Q3 		$365K Sell
17,090
-250
-1% -$5.05K ﹤0.01% 4221
2019
Q2 		$402K Sell
17,340
-43,134
-71% -$1.29M ﹤0.01% 4234
2019
Q1 		$2.33M Sell
60,474
-2,516
-4% -$109K ﹤0.01% 3653
2018
Q4 		$2.91M Buy
62,990
+3,802
+6% +$282K ﹤0.01% 3566
2018
Q3 		$8.08M Buy
59,188
+15,057
+34% +$2.59M ﹤0.01% 3334
2018
Q2 		$20.8M Buy
44,131
+44,070
+72,246% +$16.2M ﹤0.01% 2831
2018
Q1 		$34K Buy
+61
New +$11.9K ﹤0.01% 4497

Other funds holding NMTR

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
SIS
Strategic Investment Solutions Orland Park, Illinois $437M AUM 30.41% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $537M AUM 12.29% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
RFA
Register Financial Advisors Atlanta, Georgia $326M AUM 48.38% 1-Year Est. Return

BlackRock's NMTR Position: Q3 2023 in Review

BlackRock sold out of 9 Meters Biopharma (NMTR) in Q3 2023, closing a stake of 167,949 shares — an estimated $113K sold.

BlackRock first reported a position in NMTR in Q1 2018 and held it in 22 quarters. The position peaked at $20.8M in Q2 2018. 6 funds tracked by Wall St. Rank hold NMTR as of Q3 2023.

  • BlackRock reported no remaining 9 Meters Biopharma position as of Q3 2023 after selling out during the quarter.
  • BlackRock sold 167,949 9 Meters Biopharma shares in Q3 2023, an estimated $113K.
  • BlackRock first reported a position in 9 Meters Biopharma in Q1 2018 and held it in 22 quarters.
  • BlackRock's 9 Meters Biopharma position peaked at $20.8M in Q2 2018.
  • 6 funds tracked by Wall St. Rank held 9 Meters Biopharma as of Q3 2023.

Based on BlackRock's 13F filing for Q3 2023, filed 13 Nov 2023.